US Broker Ratings

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Innovator with a Potential Downside Amidst Industry Challenges

CureVac N.V. (NASDAQ: CVAC), a prominent player in the burgeoning field of mRNA technology, has captured investor attention with its innovative approach to developing transformative medicines. Headquartered in Tübingen, Germany,..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring 34.28% Potential Upside with Robust SaaS Solutions

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, has been making waves in the healthcare sector with its innovative Software-as-a-Service (SaaS) solutions. Headquartered in Nashville,..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Unpacking the Biotech Player’s 52-Week Highs and Analyst Optimism

Sionna Therapeutics, Inc. (NASDAQ: SION) is capturing headlines and investor interest as a burgeoning player in the biotech sector, particularly due to its focus on innovative treatments for cystic fibrosis..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring a 27.76% Potential Upside in the Biotechnology Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at a pivotal juncture in the biotechnology space, presenting an intriguing opportunity for investors keen on the healthcare sector. Despite its challenges, the company’s..

AxoGen, Inc. (AXGN) Stock Analysis: Navigating High Growth in the Medical Device Sector

AxoGen, Inc. (NASDAQ: AXGN), a company specializing in peripheral nerve regeneration technologies, is making waves in the healthcare sector with its innovative medical devices. Headquartered in Alachua, Florida, AxoGen is..

Immunome, Inc. (IMNM) Stock Analysis: Strong Buy Ratings and 32.73% Potential Upside

Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology firm headquartered in Bothell, Washington, is capturing investor attention with its robust pipeline of targeted cancer therapies and a notable market capitalization of..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating the Healthcare Device Landscape with Strategic Focus

Avanos Medical, Inc. (AVNS), a key player in the healthcare sector, specializes in providing innovative medical device solutions across a global market. Headquartered in Alpharetta, Georgia, Avanos offers an array..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: 239% Potential Upside Makes It a Compelling Buy

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 239.62%. The company specializes in developing and commercializing therapeutics..

Oculis Holding AG (OCS) Stock Analysis: Exploring a Potential 127% Upside in Biotech Innovation

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology sector, is poised to capture investor attention with its robust potential for growth in the high-stakes healthcare arena. Based..

AnaptysBio, Inc. (ANAB) Stock Analysis: A 51.59% Potential Upside Amidst Dynamic Biotech Innovations

AnaptysBio, Inc. (NASDAQ: ANAB), a San Diego-based biotechnology firm, is capturing investor attention with a market cap of $1.18 billion and a promising array of immunology therapeutics. Operating in the..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 13.25% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the United States healthcare sector, operates a network of general acute care hospitals. With a market capitalization of $483.41 million,..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with 58% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising pipeline in the biopharmaceutical sector. As a clinical-stage biotechnology company, Trevi focuses on developing therapies for..

Replimune Group, Inc. (REPL)

⚠️ No article content returned.

..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook Reveals 71.81% Potential Upside in CNS Therapy Innovations

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a forefront player in the biotechnology sector, is capturing investor attention with its ambitious portfolio of therapies targeting central nervous system (CNS) disorders. With..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech Gem With 74% Upside Potential

Investors seeking opportunities in the biotechnology sector should turn their attention to LENZ Therapeutics, Inc. (NASDAQ: LENZ). With a market capitalization nearing $1 billion and a potential upside of 74.15%,..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a Potential 107% Upside for Investors

Owens & Minor, Inc. (NYSE: OMI), a prominent player in the healthcare sector, is navigating a challenging market environment. Operating through its two primary segments, Products & Healthcare Services and..

InMode Ltd. (INMD) Stock Analysis: Healthcare Innovator with a 19.49% Potential Upside

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in developing and marketing cutting-edge medical devices for aesthetic procedures. Based in Yokne’am, Israel, this innovative company is..

Pharvaris N.V. (PHVS) Stock Analysis: Potential 35.71% Upside for Biotech Innovator

Pharvaris N.V. (PHVS), a notable player in the biotechnology sector, is capturing investor attention with its promising focus on rare disease therapies. Headquartered in Zug, Switzerland, this late-stage biopharmaceutical company..

Avadel Pharmaceuticals (AVDL) Stock Analysis: A Healthcare Play with a 54.9% Revenue Growth Surge

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a healthcare innovator making significant strides in the drug manufacturing sector, particularly within the specialty and generic drug industry. Headquartered in Dublin, Ireland, Avadel’s..

Simulations Plus, Inc. (SLP) Stock Analysis: Unpacking a 33% Potential Upside with Robust Healthcare Software Solutions

Simulations Plus, Inc. (NASDAQ: SLP) is carving a niche within the healthcare sector, particularly in the health information services industry. The company’s software solutions for drug discovery and development leverage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds